The Metabolic syndrome and metabolic characteristics in blood donors
DOI:
https://doi.org/10.31053/1853.0605.v81.n2.42446Keywords:
Metabolic syndrome, blood donors, ObesityAbstract
Introduction: Metabolic syndrome (MS) is associated with increased cardiovascular risk. Blood donors are an apparently healthy population in which certain cardiometabolic characteristics are not evaluated in their selection, and there is limited information on their presence. Aim: To determine the frequency of metabolic syndrome and its metabolic characteristics in blood donors. Materials and methods: Cross-sectional study was carried in a population of 244 blood donors between 18 and 55 years of age who attended the Hemotherapy and Blood Bank Service of the Cayetano Heredia Hospital in Lima, Perú during the month of May 2023. The diagnosis of MS was made according to the Adult Treatment Panel III (ATP III) criteria. A bivariate analysis was performed between MS and metabolic characteristics with sex and a significance level of 5% was considered. Results: 63.9% of blood donors were male. 43.6% of the population had MS. The most frequent characteristics found were hypertriglyceridemia (54.5%), abdominal obesity (51.2%) and high-density lipoprotein (HDL) low (48.8%). The age range of 40 to 49 years presented the highest frequency of MS (14.3%). Hypertriglyceridemia and high blood pressure were associated with male sex (p=0.003 and p=0.019 respectively), while low HDL was associated with female sex (p<0.001). Conclusions: Blood donors present an elevated frequency of MS. The detection of MS in apparently healthy populations as part of primary care could allow the formulation of strategies for early detection of cardiovascular risk factors.
Downloads
References
Sanchez-Samaniego G, Mäusezahl D, Carcamo C, Probst-Hensch N, Verastegui H, Maria Hartinger S. Metabolic syndrome in rural Peruvian adults living at high altitudes using different cookstoves. PLoS One. 2022 Feb 8;17(2):e0263415.
doi: 10.1371/journal.pone.0263415.
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005 Apr 16-22;365(9468):1415-28. doi: 10.1016/S0140-6736(05)66378-7.
Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595-607. doi: 10.2337/diab.37.12.1595
Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162. doi: 10.1155/2014/943162.
Lann D, LeRoith D. Insulin resistance as the underlying cause for the metabolic syndrome. Med Clin North Am. 2007 Nov;91(6):1063-77.
doi: 10.1016/j.mcna.2007.06.012.
Desroches S, Lamarche B. The evolving definitions and increasing prevalence of the metabolic syndrome. Appl Physiol Nutr Metab. 2007 Feb;32(1):23-32.
doi: 10.1139/h06-095
Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP. The prevalence of metabolic syndrome in various populations. Am J Med Sci. 2007 Jun;333(6):362-71.
doi: 10.1097/MAJ.0b013e318065c3a1.
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002 Jan 16;287(3):356-9.
doi: 10.1001/jama.287.3.356.
Márquez-Sandoval F, Macedo-Ojeda G, Viramontes-Hörner D, Fernández Ballart JD, Salas Salvadó J, Vizmanos B. The prevalence of metabolic syndrome in Latin America: a systematic review. Public Health Nutr. 2011 Oct;14(10):1702-13.
doi: 10.1017/S1368980010003320.
Medina-Lezama J, Zea-Diaz H, Morey-Vargas OL, Bolaños-Salazar JF, Muñoz-Atahualpa E, Postigo-MacDowall M, Corrales-Medina F, Valdivia-Ascuña Z, Cuba-Bustinza C, Paredes-Díaz S, Villalobos-Tapia P, Chirinos-Pacheco J, Goldberg RB, Chirinos JA. Prevalence of the metabolic syndrome in Peruvian Andean hispanics: the PREVENCION study. Diabetes Res Clin Pract. 2007 Nov;78(2):270-81.
doi: 10.1016/j.diabres.2007.04.004.
Cruz del Castillo AH, García Fierro R, Hess Moreno MI, Vigil Pérez CA, Córdova Fernández JA, Chuck Santiago MP, Domínguez Moreno R. Prevalencia de síndrome metabólico y características clínicas en donadores de sangre [Metabolic syndrome prevalence and clinical features in blood donors]. Rev Fac Cien Med Univ Nac Cordoba. 2012;69(3):144-9. Spanish. PMID: 23286576.
Munguía-Miranda C, Sánchez-Barrera RG, Tuz K, Alonso-García AL, Cruz M. Detección de glucosa en ayuno alterada en donadores de sangre [Impaired fasting glucose detection in blood donors population]. Rev Med Inst Mex Seguro Soc. 2009 Jan-Feb;47(1):17-24. Spanish. PMID: 19624959.
Agarwal P, Gautam A, Pursnani N, Jain A, Singh N, Singh B, Parihar A. Should screening voluntary blood donors be used as strategy to diagnose diabetes and diabetic nephropathy? J Family Med Prim Care. 2020 Jul 30;9(7):3582-3585.
doi: 10.4103/jfmpc.jfmpc_229_20.
Torezan-Filho MA, Alves VA, Neto CA, Fernandes HS, Strauss E. Clinical significance of elevated alanine aminotransferase in blood donors: a follow-up study. Liver Int. 2004 Dec;24(6):575-81. doi: 10.1111/j.1478-3231.2004.0970.x.
Perú. Ministerio de Saludo. Resolución Ministerial N.° 241-2018-MINSA [Internet]. www.gob.pe. [cited 2023 Sep 9]. Disponible en: https://www.gob.pe/institucion/minsa/normas-legales/187434-241-2018-minsa.
Pajuelo, J; Sánchez-Abanto, J; Torres, H. y Miranda, M. Prevalencia del síndrome metabólico en pobladores peruanos por debajo de 1 000 y por encima de los 3 000 msnm. An. Fac. med. 2012;73(2):101-106.
Peffer K, Verbeek AL, Swinkels DW, Geurts-Moespot AJ, den Heijer M, Atsma F. Donation intensity and metabolic syndrome in active whole-blood donors. Vox Sang. 2015 Jul;109(1):25-34.
doi: 10.1111/vox.12258.
Hirode G, Wong RJ. Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016. JAMA. 2020 Jun 23;323(24):2526-2528.
doi: 10.1001/jama.2020.4501.
Gouveia ÉR, Gouveia BR, Marques A, Peralta M, França C, Lima A, Campos A, Jurema J, Kliegel M, Ihle A. Predictors of Metabolic Syndrome in Adults and Older Adults from Amazonas, Brazil. Int J Environ Res Public Health. 2021 Feb 1;18(3):1303. doi: 10.3390/ijerph18031303.
Njelekela MA, Mpembeni R, Muhihi A, Mligiliche NL, Spiegelman D, Hertzmark E, Liu E, Finkelstein JL, Fawzi WW, Willett WC, Mtabaji J. Gender-related differences in the prevalence of cardiovascular disease risk factors and their correlates in urban Tanzania. BMC Cardiovasc Disord. 2009 Jul 17;9:30. doi: 10.1186/1471-2261-9-30.
Beigh SH, Jain S. Prevalence of metabolic syndrome and gender differences. Bioinformation. 2012;8(13):613-6.
doi: 10.6026/97320630008613.
Bani M, Strepparava M, Giussani B. Gender differences and frequency of whole blood donation in Italian donors: even though I want to, I cannot? Transfus Apher Sci. 2014 Feb;50(1):81-6.
doi: 10.1016/j.transci.2013.11.001.
Adams KJ, Chirinos JL. Prevalence of Risk Factors for Metabolic Syndrome and Its Components in Community Kitchen Users in a District in Lima, Peru. Rev Peru Med Exp Salud Publica. 2018 Jan-Mar;35(1):39-45. doi:10.17843/rpmesp.2018.351.3598.
Espinoza-Rivera S, Rivera P, Ballinas-Sueldo Y. Prevalencia y componentes del síndrome metabólico premórbido en trabajadores asegurados al seguro social de salud en una zona de altitud moderada en Perú. Acta méd. Perú. 2022; 39( 4 ): 362-368. doi:10.35663/amp.2022.394.2505.
Sniderman AD, Couture P, Martin SS, DeGraaf J, Lawler PR, Cromwell WC, Wilkins JT, Thanassoulis G. Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding. J Lipid Res. 2018 Jul;59(7):1266-1275. doi: 10.1194/jlr.R082271
Reiner Ž. Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol. 2017 Jul;14(7):401-411. doi: 10.1038/nrcardio.2017.31.
Haverinen E, Paalanen L, Palmieri L, Padron-Monedero A, Noguer-Zambrano I, Sarmiento Suárez R, Tolonen H; Joint Action on Health Information (InfAct). Comparison of metabolic syndrome prevalence using four different definitions - a population-based study in Finland. Arch Public Health. 2021 Dec 23;79(1):231. doi: 10.1186/s13690-021-00749-3.
Raposo L, Severo M, Barros H, Santos AC. The prevalence of the metabolic syndrome in Portugal: the PORMETS study. BMC Public Health. 2017 Jun 8;17(1):555. doi: 10.1186/s12889-017-4471-9.
Roca-Sanchez-Moreno JD, Soto A, Núñez-Muñoz AL, De La Cruz-Vargas JA, Quiñones-Laveriano DM. Comparison of different definitions of metabolic syndrome and their relationship with cardiovascular risk estimation. Rev. Fac. Med. 2022;70(2):e92602. doi:10.15446/revfacmed.v70n2.92602.
Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009 May-Jun;2(5-6):231-7.
doi: 10.1242/dmm.001180.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).
